Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.14064 ◽

2017 ◽

Vol 45 (12) ◽

pp. 1524-1533 ◽

Author(s):

C. Coyle ◽

G. Crawford ◽

J. Wilkinson ◽

S. J. Thomas ◽

P. Bytzer

Keyword(s):

Clinical Trial ◽

Proton Pump Inhibitor ◽

Proton Pump ◽

Randomised Clinical Trial ◽

Proton Pump Inhibitor Therapy ◽

Inhibitor Therapy

Download Full-text

Proton-pump inhibitor therapy for acetylsalicylic acid associated upper gastrointestinal symptoms, a randomised clinical trial

Gastroenterology ◽

10.1016/s0016-5085(03)82589-1 ◽

2003 ◽

Vol 124 (4) ◽

pp. A511

Author(s):

Robert J.F. Laheij ◽

Leo G.M. Van Rossum ◽

Jan B.M. Jansen ◽

Freek W.A. Verheught

Keyword(s):

Clinical Trial ◽

Proton Pump Inhibitor ◽

Acetylsalicylic Acid ◽

Proton Pump ◽

Gastrointestinal Symptoms ◽

Randomised Clinical Trial ◽

Proton Pump Inhibitor Therapy ◽

Inhibitor Therapy ◽

Upper Gastrointestinal Symptoms ◽

Upper Gastrointestinal

Download Full-text

Faculty Opinions recommendation of Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727578166.793536946 ◽

2017 ◽

Author(s):

Maura Corsetti

Keyword(s):

Clinical Trial ◽

Proton Pump Inhibitor ◽

Proton Pump ◽

Randomised Clinical Trial ◽

Proton Pump Inhibitor Therapy ◽

Inhibitor Therapy

Download Full-text

Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.13194 ◽

2015 ◽

Vol 41 (11) ◽

pp. 1162-1174 ◽

Author(s):

S. E. Attwood ◽

C. Ell ◽

J. P. Galmiche ◽

R. Fiocca ◽

J. G. Hatlebakk ◽

...

Keyword(s):

Clinical Trial ◽

Proton Pump Inhibitor ◽

Proton Pump ◽

Randomised Clinical Trial ◽

Proton Pump Inhibitor Therapy ◽

Inhibitor Therapy

Download Full-text

925h Transoral Fundoplication vs. Proton Pump Inhibitor Therapy For Treatment of Chronic Gastroesophageal Reflux: Short-term Results From a Multicenter, Randomized, Open Label Clinical Trial

Gastroenterology ◽

10.1016/s0016-5085(13)60586-7 ◽

2013 ◽

Vol 144 (5) ◽

pp. S-163-S-164 ◽

Author(s):

Karim S. Trad ◽

William E. Barnes ◽

Gilbert Simoni ◽

Ahmad B. Shughoury ◽

Mamoon Raza ◽

...

Keyword(s):

Clinical Trial ◽

Proton Pump Inhibitor ◽

Gastroesophageal Reflux ◽

Proton Pump ◽

Proton Pump Inhibitor Therapy ◽

Inhibitor Therapy ◽

Download Full-text

The GABA, agonist baclofen reduces duodeno-gastro-esophageal reflux (DGER) and symptoms in patients with reflux disease refractory to proton pump inhibitor therapy

Gastroenterology ◽

10.1016/s0016-5085(01)80167-0 ◽

2001 ◽

Vol 120 (5) ◽

pp. A34-A34 ◽

Author(s):

G KOEK ◽

D SIFRIM ◽

T DEGREEF ◽

J JANSSENS ◽

J TACK

Keyword(s):

Proton Pump Inhibitor ◽

Proton Pump ◽

Reflux Disease ◽

Proton Pump Inhibitor Therapy ◽

Inhibitor Therapy ◽

Esophageal Reflux ◽

Download Full-text

Ursache und Therapie des kardialen Syndrom X – Ergebnisse der monozentrischen PITFALL-Studie (Proton pump Inhibitor Therapy For Angina-Like Lingering pain)

Zeitschrift für Gastroenterologie ◽

10.1055/s-0028-1096441 ◽

2008 ◽

Vol 46 (10) ◽

Author(s):

CG Dietrich ◽

S Laupichler ◽

S Stanzel ◽

R Winograd ◽

O Al-Taie ◽

...

Keyword(s):

Proton Pump Inhibitor ◽

Proton Pump ◽

Proton Pump Inhibitor Therapy ◽

Inhibitor Therapy

Download Full-text

Faculty Opinions recommendation of Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1160573.620941 ◽

2009 ◽

Author(s):

Waqar Qureshi

Keyword(s):

Proton Pump Inhibitor ◽

Proton Pump ◽

Spontaneous Bacterial Peritonitis ◽

Proton Pump Inhibitor Therapy ◽

Inhibitor Therapy ◽

Bacterial Peritonitis ◽

Cirrhotic Patients

Download Full-text

Faculty Opinions recommendation of Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1162614.624823 ◽

2009 ◽

Author(s):

Peter Katelaris

Keyword(s):

Proton Pump Inhibitor ◽

Healthy Volunteers ◽

Proton Pump ◽

Proton Pump Inhibitor Therapy ◽

Inhibitor Therapy ◽

Withdrawal Of Therapy

Download Full-text

Faculty Opinions recommendation of Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.2274956.1895054 ◽

2010 ◽

Author(s):

Klaus Bielefeldt

Keyword(s):

Proton Pump Inhibitor ◽

Proton Pump ◽

Bacterial Overgrowth ◽

Small Intestinal Bacterial Overgrowth ◽

Proton Pump Inhibitor Therapy ◽

Inhibitor Therapy ◽

Intestinal Bacterial Overgrowth ◽

Small Intestinal

Download Full-text

Faculty Opinions recommendation of Proton pump inhibitor therapy improves symptoms in postnasal drainage.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.5886958.793468623 ◽

2013 ◽

Author(s):

Alkis Psaltis

Keyword(s):

Proton Pump Inhibitor ◽

Proton Pump ◽

Proton Pump Inhibitor Therapy ◽

Inhibitor Therapy

Download Full-text